MCI researchers present 12 studies on GYN cancers at meeting
Twelve studies by the Division of Gynecologic Oncology at USA Health Mitchell Cancer Institute were accepted for oral or poster presentations at the national Society of Gynecologic Oncology’s 50th Annual Meeting on Women’s Cancer.
Twelve studies by the Division of Gynecologic Oncology at USA Health Mitchell Cancer Institute were accepted for oral or poster presentations at the national Society of Gynecologic Oncology’s 50th Annual Meeting on Women’s Cancer.
The research covered topics such as HPV vaccination rates in Alabama counties, racial disparities in ovarian cancer outcomes and an ovarian cancer drug being tested in hens in collaboration with Auburn University. Overall, approximately 50 oral presentations and 600 poster presentations were accepted for the annual SGO meeting, which was held in Honolulu March 16-19.
“I am extremely proud of the number of research reports and posters that were accepted from MCI and are being highlighted at this meeting,” said Dr. Rodney P. Rocconi, interim director of the Mitchell Cancer Institute. “This is quite an achievement for a cancer center of our size.”
Rocconi and fellow gynecologic oncologist Dr. Jennifer Young Pierce of MCI presented two studies at the meeting. Among the eight poster presentations from MCI was the study of a new modified early-warning system built to raise the level of care for gynecologic cancer patients in the hospital.
MCI oncologists also collaborated with other cancer centers, including Memorial Sloan Kettering, on a study of the use of minimally invasive surgery for cervical cancer patients. These results were presented at the meeting.
SGO has roughly 2,000 members representing gynecologic oncology in the U.S. and abroad, including gynecologic oncologists, medical oncologists, pathologists, radiation oncologists, hematologists, surgical oncologists, OB/GYNs, nurses, physician assistants, social workers, fellows, residents and other allied health-care professionals who work in the treatment and care of women’s cancer.
“This event will showcase the excellent scientific research that is taking place at USA Health Mitchell Cancer Institute and at the University of South Alabama College of Medicine,” said Dr. John V. Marymont, vice president for medical affairs and dean of the College of Medicine.
About Mitchell Cancer Institute
As the region's only academic cancer center, USA Health Mitchell Cancer Institute combines NIH-funded scientific research with comprehensive cancer care serving communities across southern Alabama, southeast Mississippi and portions of northwest Florida. With three locations, more than 50 clinical trials, and five support groups, the Mitchell Cancer Institute guides patients and their families from the moment of diagnosis through survivorship.
